Literature DB >> 16783460

Antigen-specific expansion of TCR Vbeta3+ CD4+ T cells in the early stage of collagen-induced arthritis and its arthritogenic role in DBA/1J mice.

Jae-Seon Lee1, Mi-La Cho, Joo-Yeon Jhun, So-Youn Min, Ji-Hyeon Ju, Chong-Hyeon Yoon, Jun-Ki Min, Sung-Hwan Park, Ho-Youn Kim, Young-Gyu Cho.   

Abstract

To investigate type II collagen (CII)-specific CD4+ T cell receptors involving in Collagen-induced arthritis (CIA) in DBA/1J mice as a model of rheumatoid arthritis in humans, TCR Vbeta usage in draining lymph nodes (dLNs) was assessed by flow cytometric analysis at 3, 5, and 8 weeks after bovine CII immunizations. In the early stage of CIA, the draining lymph node CD4+ T cells from CIA mice showed a higher proportion of CD4+ Vbeta3+ subsets compared with those from control mice. The CD4+ Vbeta3+ T cells were specifically and primarily expanded by antigen-specific stimulation in in vitro culture of dLNs lymphocytes and splenocytes from CIA mice. In addition, CII-reactive response was observed when CD4+ Vbeta3+ T cells were added to a non-responding T cell population. The adoptive transfer of CD4+ Vbeta3+ T cells produced exaggerated arthritis compared with that in the control group. Our results indicate that CD4+ Vbeta3+ T cells, which were selectively expanded in dLN of CIA mice, play a pivotal role in CIA pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16783460     DOI: 10.1007/s10875-006-9012-8

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  23 in total

Review 1.  Type II collagen autoimmunity in animals and provocations leading to arthritis.

Authors:  R Holmdahl; M Andersson; T J Goldschmidt; K Gustafsson; L Jansson; J A Mo
Journal:  Immunol Rev       Date:  1990-12       Impact factor: 12.988

2.  A recurrent valpha17/vbeta10 TCR-expressing T cell clone is involved in the pathogenicity of collagen-induced arthritis in DBA/1 mice.

Authors:  A Doncarli; G Chiocchia; L M Stasiuk; D Herbage; M M Boutillon; C Fournier; O Abehsira-Amar
Journal:  Eur J Immunol       Date:  1999-11       Impact factor: 5.532

3.  The T-cell repertoire is heavily influenced by tolerance to polymorphic self-antigens.

Authors:  A M Pullen; P Marrack; J W Kappler
Journal:  Nature       Date:  1988-10-27       Impact factor: 49.962

4.  Role of T lymphocytes in murine collagen induced arthritis.

Authors:  R Holmdahl; L Klareskog; K Rubin; J Björk; G Smedegård; R Jonsson; M Andersson
Journal:  Agents Actions       Date:  1986-12

5.  Immunization with T cell receptor V beta chain peptides deletes pathogenic T cells and prevents the induction of collagen-induced arthritis in mice.

Authors:  T M Haqqi; X M Qu; D Anthony; J Ma; M S Sy
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

6.  Characterization of T cell receptor beta chains of accumulating T cells in skin allografts in mice.

Authors:  T Kato; Y Ikeda; Z P Zong; H Sasakawa; M Kurokawa; K Masuko; R Igarashi; Y Mizushima; K Nishioka; K Yamamoto
Journal:  Transplantation       Date:  1996-07-27       Impact factor: 4.939

7.  IFNgamma deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vbeta6 and Vbeta8 in arthritic joints.

Authors:  C-Q Chu; Z Song; L Mayton; B Wu; P H Wooley
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

8.  CD4+ T cells from collagen-induced arthritic mice are essential to transfer arthritis into severe combined immunodeficient mice.

Authors:  K M Kadowaki; H Matsuno; H Tsuji; I Tunru
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

9.  Possible role of V beta T cell receptor genes in susceptibility to collagen-induced arthritis in mice.

Authors:  S Banerjee; T M Haqqi; H S Luthra; J M Stuart; C S David
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

10.  Autoimmunity to type II collagen an experimental model of arthritis.

Authors:  D E Trentham; A S Townes; A H Kang
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

View more
  2 in total

1.  Suppressive effect of an orally active MEK1/2 inhibitor in two different animal models for rheumatoid arthritis: a comparison with leflunomide.

Authors:  Takayuki Yamaguchi; Reina Kakefuda; Atsuo Tanimoto; Yoshihiro Watanabe; Nobuyuki Tajima
Journal:  Inflamm Res       Date:  2012-01-14       Impact factor: 4.575

2.  FR180204, a novel and selective inhibitor of extracellular signal-regulated kinase, ameliorates collagen-induced arthritis in mice.

Authors:  Makoto Ohori; Mikio Takeuchi; Riyo Maruki; Hidenori Nakajima; Hiroshi Miyake
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-11-23       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.